Cite
HARVARD Citation
Romiti, R. et al. (2019). Prevalence and outcome of latent tuberculosis in patients receiving ixekizumab: integrated safety analysis from 11 clinical trials of patients with plaque psoriasis. British journal of dermatology. pp. 202-203. [Online].